Recent advances in small-molecule fluorescent probes with the function of targeting cancer receptors

Xinke Li1, Caiyun Liu1, Hanchuang Zhu1

  • 1School of Water Conservancy and Environment, University of Jinan, Jinan 250022, China. lcyzbc@163.com.

Insights

Small molecule fluorescent probes targeting cancer cell receptors offer advanced tumor imaging and tracking. This review explores their design, properties, and applications for improved cancer diagnosis and treatment guidance.

Area of Science:

  • Biomedical Engineering
  • Molecular Imaging
  • Oncology

Background:

  • Cancer poses a significant threat to human health, necessitating advanced diagnostic and therapeutic strategies.
  • Overexpressed receptors on cancer cells present opportunities for targeted detection and treatment.
  • Receptor-targeting strategies enhance the specificity of fluorescent probes for tumor localization.

Purpose of the Study:

  • To review the design principles of small molecule fluorescent probes for receptor-targeted cancer imaging.
  • To analyze the photophysical properties and applications of these targeted probes.
  • To discuss future directions for developing active targeting probes in oncology.

Main Methods:

  • Literature review focusing on small molecule fluorescent probes.
  • Analysis of receptor-mediated endocytosis mechanisms for probe delivery.
  • Evaluation of probe performance in cancer cell imaging and tracking.

Main Results:

  • Receptor-targeting probes enable specific imaging and tracking of cancer cells.
  • These probes aid in determining tumor boundaries and monitoring deep lesions.
  • Applications include fluorescent imaging-guided surgery and enhanced clinical diagnostics.

Conclusions:

  • Small molecule fluorescent probes targeting cancer cell surface receptors are crucial for precise tumor visualization.
  • Continued development of these probes promises significant advancements in cancer detection and surgical guidance.
  • Future research should focus on optimizing probe design for broader clinical translation and improved patient outcomes.